Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stavroula Baritaki

Showing results (41-50 of 77) with videos related to

Pageof 8
Sort By:
Journal of Clinical Microbiology|June 26, 2009
Evaluation of GenoType mycobacteria direct assay in comparison with Gen-Probe Mycobacterium tuberculosis amplified direct test and GenoType MTBDRplus for direct detection of Mycobacterium tuberculosis complex in clinical samplesIoannis K Neonakis, Zoe Gitti, Stavroula Baritaki, et al.
Leukemia & Lymphoma|December 8, 2010
A potential mechanism of rituximab-induced inhibition of tumor growth through its sensitization to tumor necrosis factor-related apoptosis-inducing ligand-expressing host cytotoxic cellsMario I Vega, Stavroula Baritaki, Sara Huerta-Yepez, et al.
Thrombosis Research|May 25, 2007
CX3CR1 receptor is up-regulated in monocytes of coronary artery diseased patients: impact of pre-inflammatory stimuli and renin-angiotensin system modulatorsStavros Apostolakis, Elias Krambovitis, Zaharenia Vlata, et al.
Antioxidants (Basel, Switzerland)|June 24, 2022
The Breast Cancer Protooncogenes HER2, BRCA1 and BRCA2 and Their Regulation by the iNOS/NOS2 AxisKatie Lin, Stavroula Baritaki, Silvia Vivarelli, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 4, 2007
Regulation of tumor cell sensitivity to TRAIL-induced apoptosis by the metastatic suppressor Raf kinase inhibitor protein via Yin Yang 1 inhibition and death receptor 5 up-regulationStavroula Baritaki, Alina Katsman, Devasis Chatterjee, et al.
Nitric Oxide : Biology and Chemistry|May 15, 2008
Novel therapeutic applications of nitric oxide donors in cancer: roles in chemo- and immunosensitization to apoptosis and inhibition of metastasesBenjamin Bonavida, Stavroula Baritaki, Sara Huerta-Yepez, et al.
Cell Cycle (Georgetown, Tex.)|December 15, 2010
Mechanisms of nitric oxide-mediated inhibition of EMT in cancer: inhibition of the metastasis-inducer Snail and induction of the metastasis-suppressor RKIPStavroula Baritaki, Sara Huerta-Yepez, Anna Sahakyan, et al.
Biochemical and Biophysical Research Communications|March 3, 2007
Biophysical characterization of V3-lipopeptide liposomes influencing HIV-1 infectivityApostolos K Rizos, Stavroula Baritaki, Ioannis Tsikalas, et al.
Advances in Cancer Research|April 17, 2007
Reversal of tumor resistance to apoptotic stimuli by alteration of membrane fluidity: therapeutic implicationsStavroula Baritaki, Stavros Apostolakis, Peggy Kanellou, et al.
International Journal of Oncology|September 6, 2007
The NO TRAIL to YES TRAIL in cancer therapy (review)Ji Yeun Lee, Sara Huerta-Yepez, Mario Vega, et al.
Pageof 8

Showing results (41-50 of 77) with videos related to

Sort By:
Pageof 8
Journal of Clinical Microbiology|June 26, 2009
Evaluation of GenoType mycobacteria direct assay in comparison with Gen-Probe Mycobacterium tuberculosis amplified direct test and GenoType MTBDRplus for direct detection of Mycobacterium tuberculosis complex in clinical samplesIoannis K Neonakis, Zoe Gitti, Stavroula Baritaki, et al.
Leukemia & Lymphoma|December 8, 2010
A potential mechanism of rituximab-induced inhibition of tumor growth through its sensitization to tumor necrosis factor-related apoptosis-inducing ligand-expressing host cytotoxic cellsMario I Vega, Stavroula Baritaki, Sara Huerta-Yepez, et al.
Thrombosis Research|May 25, 2007
CX3CR1 receptor is up-regulated in monocytes of coronary artery diseased patients: impact of pre-inflammatory stimuli and renin-angiotensin system modulatorsStavros Apostolakis, Elias Krambovitis, Zaharenia Vlata, et al.
Antioxidants (Basel, Switzerland)|June 24, 2022
The Breast Cancer Protooncogenes HER2, BRCA1 and BRCA2 and Their Regulation by the iNOS/NOS2 AxisKatie Lin, Stavroula Baritaki, Silvia Vivarelli, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 4, 2007
Regulation of tumor cell sensitivity to TRAIL-induced apoptosis by the metastatic suppressor Raf kinase inhibitor protein via Yin Yang 1 inhibition and death receptor 5 up-regulationStavroula Baritaki, Alina Katsman, Devasis Chatterjee, et al.
Nitric Oxide : Biology and Chemistry|May 15, 2008
Novel therapeutic applications of nitric oxide donors in cancer: roles in chemo- and immunosensitization to apoptosis and inhibition of metastasesBenjamin Bonavida, Stavroula Baritaki, Sara Huerta-Yepez, et al.
Cell Cycle (Georgetown, Tex.)|December 15, 2010
Mechanisms of nitric oxide-mediated inhibition of EMT in cancer: inhibition of the metastasis-inducer Snail and induction of the metastasis-suppressor RKIPStavroula Baritaki, Sara Huerta-Yepez, Anna Sahakyan, et al.
Biochemical and Biophysical Research Communications|March 3, 2007
Biophysical characterization of V3-lipopeptide liposomes influencing HIV-1 infectivityApostolos K Rizos, Stavroula Baritaki, Ioannis Tsikalas, et al.
Advances in Cancer Research|April 17, 2007
Reversal of tumor resistance to apoptotic stimuli by alteration of membrane fluidity: therapeutic implicationsStavroula Baritaki, Stavros Apostolakis, Peggy Kanellou, et al.
International Journal of Oncology|September 6, 2007
The NO TRAIL to YES TRAIL in cancer therapy (review)Ji Yeun Lee, Sara Huerta-Yepez, Mario Vega, et al.
Pageof 8